Please enable JavaScript to continue using this application.

Compare $ABEO vs $LRMR | Chartloom

Compare

$ABEO vs $LRMR

Abeona Therapeutics Inc · Larimar Therapeutics Inc

ABEO

Abeona Therapeutics Inc

LRMR

Larimar Therapeutics Inc

Compare $ABEO vs $LRMR

Comparing Abeona Therapeutics Inc and Larimar Therapeutics Inc

ABEOAbeona Therapeutics Inc

LRMRLarimar Therapeutics Inc

ABEOAbeona Therapeutics Inc

Market cap

$282M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.20x

Rev growth (TTM)

6280.0%

YTD performance

-7.0%

52W performance

-10.8%

FCF yield

-29.0%

LRMRLarimar Therapeutics Inc

Market cap

$277M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-23.1%

52W performance

-44.6%

FCF yield

-56.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

ABEO

LRMR

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

LRMR

Larimar Therapeutics Inc

Market Cap

ABEO$282M

LRMR$277M

Enterprise Value

ABEO$240M

LRMR$185M

Price

ABEO$4.94

LRMR$2.67

P/E Ratio

ABEON/A

LRMRN/A

P/S Ratio

ABEO11.03x

LRMR0.00x

EV/Sales

ABEO9.42x

LRMR0.00x

EV/EBITDA

ABEO3.95x

LRMR0.00x

P/B Ratio

ABEO2.25x

LRMR2.41x

P/FCF Ratio

ABEON/A

LRMRN/A

EV/FCF

ABEO-2.95x

LRMR-1.18x

PEG Ratio

ABEON/A

LRMRN/A

Forward P/E (NTM)

ABEON/A

LRMRN/A

Forward P/S (NTM)

ABEO3.20x

LRMRN/A

Revenue (TTM)

ABEO$26M

LRMR$0

Revenue Growth (YoY)

ABEO6280.0%

LRMRN/A

Forward Rev Growth

ABEO131.0%

LRMR290.4%

Gross Margin (TTM)

ABEO67.1%

LRMR0.0%

Operating Margin (TTM)

ABEO0.0%

LRMR0.0%

EBITDA Margin (TTM)

ABEO-316.6%

LRMR0.0%

Net Margin (TTM)

ABEO-246.4%

LRMR0.0%

FCF Margin (TTM)

ABEO-319.5%

LRMRN/A

Net Income (TTM)

ABEO$-63M

LRMR$-173M

FCF (TTM)

ABEO$-82M

LRMR$-156M

EPS (TTM)

ABEO-$1.10

LRMR-$1.66

ROE (TTM)

ABEO-4169.0%

LRMR-13739.0%

ROA (TTM)

ABEO-3036.0%

LRMR-9765.0%

ROIC (TTM)

ABEO-3719.0%

LRMR-13739.0%

Cash

ABEO$56M

LRMR$93M

Debt

ABEO$15M

LRMR$0

Net Cash/Debt

ABEO$41M

LRMR$93M

Current Ratio (TTM)

ABEO6.63x

LRMR4.70x

Quick Ratio (TTM)

ABEO6.32x

LRMR4.58x

Debt/Equity (TTM)

ABEO0.12x

LRMR0.00x

Debt/Assets (TTM)

ABEO0.0%

LRMR0.0%

Interest Coverage (TTM)

ABEON/A

LRMRN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

LRMR0.00x

Beta

ABEO1.45

LRMR0.68

52W Performance

ABEO-10.8%

LRMR-44.6%

YTD Performance

ABEO-7.0%

LRMR-23.1%

% from 52W High

ABEO-35.4%

LRMR-58.4%

% from 52W Low

ABEO23.5%

LRMR2.3%

Asset Turnover (TTM)

ABEO0.13x

LRMR0.00x

FCF Yield (TTM)

ABEO-29.0%

LRMR-56.3%

Earnings Yield (TTM)

ABEO-22.3%

LRMR-62.2%

Dividend Yield (TTM)

ABEON/A

LRMRN/A

Rule of 40

ABEO5,960.5

LRMR0.0

EV/GP/RG

ABEO0.04

LRMRN/A

Ticker research

View ABEO research View LRMR research

Metric	ABEO Abeona Therapeutics Inc	LRMR Larimar Therapeutics Inc
Market & Valuation
Market Cap	$282M	$277M
Enterprise Value	$240M	$185M
Price	$4.94	$2.67
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	0.00x
EV/Sales	9.42x	0.00x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	2.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-1.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	N/A
Revenue & Growth
Revenue (TTM)	$26M	$0
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	290.4%
Profitability
Gross Margin (TTM)	67.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	0.0%
Net Margin (TTM)	-246.4%	0.0%
FCF Margin (TTM)	-319.5%	N/A
Net Income (TTM)	$-63M	$-173M
FCF (TTM)	$-82M	$-156M
EPS (TTM)	-$1.10	-$1.66
ROE (TTM)	-4169.0%	-13739.0%
ROA (TTM)	-3036.0%	-9765.0%
ROIC (TTM)	-3719.0%	-13739.0%
Financial Health
Cash	$56M	$93M
Debt	$15M	$0
Net Cash/Debt	$41M	$93M
Current Ratio (TTM)	6.63x	4.70x
Quick Ratio (TTM)	6.32x	4.58x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.68
52W Performance	-10.8%	-44.6%
YTD Performance	-7.0%	-23.1%
% from 52W High	-35.4%	-58.4%
% from 52W Low	23.5%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-29.0%	-56.3%
Earnings Yield (TTM)	-22.3%	-62.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	0.0
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View LRMR research

Valuation

P/S Ratio

LRMR

0.00x

ABEO

11.03x

EV/FCF

ABEO

-2.95x

LRMR

-1.18x

Growth & revenue

Revenue Growth TTM

ABEO

6280.0%

Forward Revenue Growth

LRMR

290.4%

ABEO

131.0%

Profitability & performance

Gross Margin

ABEO

67.1%

LRMR

0.0%

ROE

ABEO

-4169.0%

LRMR

-13739.0%

FCF Yield %

ABEO

-29.0%

LRMR

-56.3%

52-Week Performance

ABEO

-10.8%

LRMR

-44.6%

Detailed metrics comparison

ABEO

Abeona Therapeutics Inc

LRMR

Larimar Therapeutics Inc

Market Cap

ABEO$282M

LRMR$277M

Enterprise Value

ABEO$240M

LRMR$185M

Price

ABEO$4.94

LRMR$2.67

P/E Ratio

ABEON/A

LRMRN/A

P/S Ratio

ABEO11.03x

LRMR0.00x

EV/Sales

ABEO9.42x

LRMR0.00x

EV/EBITDA

ABEO3.95x

LRMR0.00x

P/B Ratio

ABEO2.25x

LRMR2.41x

P/FCF Ratio

ABEON/A

LRMRN/A

EV/FCF

ABEO-2.95x

LRMR-1.18x

PEG Ratio

ABEON/A

LRMRN/A

Forward P/E (NTM)

ABEON/A

LRMRN/A

Forward P/S (NTM)

ABEO3.20x

LRMRN/A

Revenue (TTM)

ABEO$26M

LRMR$0

Revenue Growth (YoY)

ABEO6280.0%

LRMRN/A

Forward Rev Growth

ABEO131.0%

LRMR290.4%

Gross Margin (TTM)

ABEO67.1%

LRMR0.0%

Operating Margin (TTM)

ABEO0.0%

LRMR0.0%

EBITDA Margin (TTM)

ABEO-316.6%

LRMR0.0%

Net Margin (TTM)

ABEO-246.4%

LRMR0.0%

FCF Margin (TTM)

ABEO-319.5%

LRMRN/A

Net Income (TTM)

ABEO$-63M

LRMR$-173M

FCF (TTM)

ABEO$-82M

LRMR$-156M

EPS (TTM)

ABEO-$1.10

LRMR-$1.66

ROE (TTM)

ABEO-4169.0%

LRMR-13739.0%

ROA (TTM)

ABEO-3036.0%

LRMR-9765.0%

ROIC (TTM)

ABEO-3719.0%

LRMR-13739.0%

Cash

ABEO$56M

LRMR$93M

Debt

ABEO$15M

LRMR$0

Net Cash/Debt

ABEO$41M

LRMR$93M

Current Ratio (TTM)

ABEO6.63x

LRMR4.70x

Quick Ratio (TTM)

ABEO6.32x

LRMR4.58x

Debt/Equity (TTM)

ABEO0.12x

LRMR0.00x

Debt/Assets (TTM)

ABEO0.0%

LRMR0.0%

Interest Coverage (TTM)

ABEON/A

LRMRN/A

Net Debt/EBITDA (TTM)

ABEO0.00x

LRMR0.00x

Beta

ABEO1.45

LRMR0.68

52W Performance

ABEO-10.8%

LRMR-44.6%

YTD Performance

ABEO-7.0%

LRMR-23.1%

% from 52W High

ABEO-35.4%

LRMR-58.4%

% from 52W Low

ABEO23.5%

LRMR2.3%

Asset Turnover (TTM)

ABEO0.13x

LRMR0.00x

FCF Yield (TTM)

ABEO-29.0%

LRMR-56.3%

Earnings Yield (TTM)

ABEO-22.3%

LRMR-62.2%

Dividend Yield (TTM)

ABEON/A

LRMRN/A

Rule of 40

ABEO5,960.5

LRMR0.0

EV/GP/RG

ABEO0.04

LRMRN/A

Ticker research

View ABEO research View LRMR research

Metric	ABEO Abeona Therapeutics Inc	LRMR Larimar Therapeutics Inc
Market & Valuation
Market Cap	$282M	$277M
Enterprise Value	$240M	$185M
Price	$4.94	$2.67
P/E Ratio	N/A	N/A
P/S Ratio	11.03x	0.00x
EV/Sales	9.42x	0.00x
EV/EBITDA	3.95x	0.00x
P/B Ratio	2.25x	2.41x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.95x	-1.18x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.20x	N/A
Revenue & Growth
Revenue (TTM)	$26M	$0
Revenue Growth (YoY)	6280.0%	N/A
Forward Rev Growth	131.0%	290.4%
Profitability
Gross Margin (TTM)	67.1%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-316.6%	0.0%
Net Margin (TTM)	-246.4%	0.0%
FCF Margin (TTM)	-319.5%	N/A
Net Income (TTM)	$-63M	$-173M
FCF (TTM)	$-82M	$-156M
EPS (TTM)	-$1.10	-$1.66
ROE (TTM)	-4169.0%	-13739.0%
ROA (TTM)	-3036.0%	-9765.0%
ROIC (TTM)	-3719.0%	-13739.0%
Financial Health
Cash	$56M	$93M
Debt	$15M	$0
Net Cash/Debt	$41M	$93M
Current Ratio (TTM)	6.63x	4.70x
Quick Ratio (TTM)	6.32x	4.58x
Debt/Equity (TTM)	0.12x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.45	0.68
52W Performance	-10.8%	-44.6%
YTD Performance	-7.0%	-23.1%
% from 52W High	-35.4%	-58.4%
% from 52W Low	23.5%	2.3%
Efficiency & Yields
Asset Turnover (TTM)	0.13x	0.00x
FCF Yield (TTM)	-29.0%	-56.3%
Earnings Yield (TTM)	-22.3%	-62.2%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	5,960.5	0.0
EV/GP/RG	0.04	N/A
Ticker research	View ABEO research	View LRMR research